Abstract:Because adult cardiomyocytes have little regenerative capacity, resident cardiac fibroblasts (CFs) synthesize extracellular matrix after myocardial infarction (MI) to form fibrosis, leading to cardiac dysfunction and heart failure. Therapies that can regenerate the myocardium and reverse fibrosis in chronic MI are lacking. The overexpression of cardiac transcription factors, including Mef2c/Gata4/Tbx5/Hand2 (MGTH), can directly reprogram CFs into induced cardiomyocytes (iCMs) and improve cardiac function under acute MI. However, the ability of in vivo cardiac reprogramming to repair chronic MI with established scars is undetermined. We generated a novel Tcf21 iCre /reporter/MGTH2A transgenic mouse system in which tamoxifen treatment could induce both MGTH and reporter expression in the resident CFs for cardiac reprogramming and fibroblast lineage tracing. We first tested the efficacy of this transgenic system in vitro and in vivo for acute MI. Next, we analyzed in vivo cardiac reprogramming and fusion events under chronic MI using Tcf21 iCre /Tomato/MGTH2A and Tcf21 iCre /mTmG/MGTH2A mice, respectively. Microarray and single-cell RNA sequencing were performed to determine the mechanism of cardiac repair by in vivo reprogramming. We confirmed the efficacy of transgenic in vitro and in vivo cardiac reprogramming for acute MI. In chronic MI, in vivo cardiac reprogramming converted ≈2% of resident CFs into iCMs, in which a majority of iCMs were generated by means of bona fide cardiac reprogramming rather than by fusion with cardiomyocytes. Cardiac reprogramming significantly improved myocardial contraction and reduced fibrosis in chronic MI. Microarray analyses revealed that the overexpression of MGTH activated cardiac program and concomitantly suppressed fibroblast and inflammatory signatures in chronic MI. Single-cell RNA sequencing demonstrated that resident CFs consisted of 7 subclusters, in which the profibrotic CF population increased under chronic MI. Cardiac reprogramming suppressed fibroblastic gene expression in chronic MI by means of conversion of profibrotic CFs to a quiescent antifibrotic state. MGTH overexpression induced antifibrotic effects partly by suppression of Meox1, a central regulator of fibroblast activation. These results demonstrate that cardiac reprogramming could repair chronic MI by means of myocardial regeneration and reduction of fibrosis. These findings present opportunities for the development of new therapies for chronic MI and heart failure.

Transient induction of actin cytoskeletal remodeling associated with dedifferentiation, proliferation, and redifferentiation stimulates cardiac regeneration

Acquired control over proliferation and differentiation of ventricular cardiomyocytes to break down the mechanisms of cardiac repair

Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction

Cardiac regeneration: Pre-existing cardiomyocyte as the hub of novel signaling pathway

Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart

Abstract 473: Induced Cardiomyocyte Cell Cycle After Myocardial Infarction Restarts the Neonatal Cardio-protective Signaling and Improves Wound Healing

Heart repair by reprogramming non-myocytes with cardiac transcription factors

Abstract 14391: Transient Cell Cycle Induction in Cardiomyocytes is a Promising Approach to Treat Ischemia Induced Heart Failure

Cardiomyocyte Dedifferentiation and Remodeling in 3D Scaffolds to Generate the Cellular Diversity of Engineering Cardiac Tissues

ASSA13-03-18 Precondition with CyclinA2 Promote Cardiac Regeneration after Myocardium Infarction Via the Recruitment of C-Kit+ Cells

The orchestration of cell-cycle reentry and ribosome biogenesis network is critical for cardiac repair

Induction of Wnt Signaling Antagonists and P21-Activated Kinase Enhances Cardiomyocyte Proliferation During Zebrafish Heart Regeneration.

Cited4a limits cardiomyocyte dedifferentiation and proliferation during zebrafish heart regeneration

Cardiac commitment driven by MyoD expression in pericardial stem cells

Repair Injured Heart by Regulating Cardiac Regenerative Signals

Single-cell chromatin profiling reveals genetic programs activating proregenerative states in nonmyocyte cells

Abstract 10618: Modified Rna Ccnd2 Promotes Myocardial Remuscularizationin Lv Infarct by Regulating Cardiomyocyte Cell Cycle

Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration

Long Non-coding RNA ECRAR Triggers Post-natal Myocardial Regeneration by Activating ERK1/2 Signaling

Cardiac regeneration: cardiomyocyte proliferation and direct transdifferentiation from somatic cells

Dynamic Transcriptional Responses To Injury Of Regenerative And Non-Regenerative Cardiomyocytes Revealed By Single-Nucleus Rna Sequencing (Vol 53, Pg 102, 2020)